An Integrated Analysis of the Safety of Tofacitinib in Psoriatic Arthritis across Phase III and Long-Term Extension Studies with Comparison to Real-World Observational Data.
Saved in:
| Title: | An Integrated Analysis of the Safety of Tofacitinib in Psoriatic Arthritis across Phase III and Long-Term Extension Studies with Comparison to Real-World Observational Data. |
|---|---|
| Authors: | Burmester, Gerd R.1 (AUTHOR), Curtis, Jeffrey R.2 (AUTHOR), Yun, Huifeng2 (AUTHOR), FitzGerald, Oliver3 (AUTHOR), Winthrop, Kevin L.4 (AUTHOR), Azevedo, Valderilio F.5 (AUTHOR), Rigby, William F. C.6 (AUTHOR), Kanik, Keith S.7 (AUTHOR), Wang, Cunshan7 (AUTHOR), Biswas, Pinaki8 (AUTHOR), Jones, Thomas9 (AUTHOR), Palmetto, Niki8 (AUTHOR), Hendrikx, Thijs9 (AUTHOR), Menon, Sujatha7 (AUTHOR), Rojo, Ricardo7 (AUTHOR) ricardo.rojo@pfizer.com |
| Source: | Drug Safety. Apr2020, Vol. 43 Issue 4, p379-392. 14p. |
| Database: | Environment Complete |
| ISSN: | 01145916 |
|---|---|
| DOI: | 10.1007/s40264-020-00904-9 |
